Northrop Grumman heads into its third-quarter report with an unusual disconnect. Three months ago management delivered its first outright guidance raise of the year, lifted its bookings outlook, and pointed to a record $105 billion backlog. Since then the stock has slipped about 2% while the S&P 500 gained roughly 4%, leaving shares near the bottom of their post-earnings range. The October 20 report, due before the open, needs to show whether that raise was the start of a trend or a high-water mark.

The Street is looking for earnings of $7.21 a share on revenue of $11.06 billion. That implies sales growth of about 6% from a year ago, slightly faster than the 5% pace of the first two quarters, while earnings are expected to fall about 6% from last year's $7.67. The Earnings Whisper sits higher at $7.45, a meaningful gap suggesting the people closest to the stock expect Northrop to clear consensus again, as it did last quarter with $7.68. The more striking comparison is with guidance. Management now calls for full-year EPS of $28.60 to $29.10, yet consensus stands near $27.96, below even the low end of that range. Revenue expectations of about $43.96 billion sit right at the roughly $44 billion midpoint. In other words, analysts accept the sales story but have not fully bought into the $1.20 EPS increase, partly because some of the second-quarter lift came from tax benefits rather than operations.

That skepticism points directly to margins, and to two problem programs. The Stand-in Attack Weapon took a $68 million unfavorable charge last quarter tied to Argon ER testing delays, pulling Defense Systems margins down to 7.5% from 9.7% in the first quarter. Space absorbed another adjustment on the GEM 63 XL solid rocket motor following its early-year launch anomaly, and its full-year margin target was cut to the low 10% range. Management argued that excluding those programs, company margins run in the high 11s and both segments near 11%. This quarter is the first real test of that containment claim. A clean quarter with no new charges, and redesigned GEM 63 XL motors on track for year-end delivery, would validate it. Another adjustment on either program, or a new one elsewhere in tactical missiles, would suggest the issues are less isolated than advertised.

The bullish side of the ledger rests on Aeronautics and Mission Systems. Aeronautics posted 13% growth and a 10.3% margin last quarter and had its full-year targets raised, while Mission Systems margin guidance moved up to about 15%. Sustaining those levels matters because they are carrying the raise while Space works through HALO and Gateway restructuring pressure. Bookings are the other proof point. After a 1.84 book-to-bill in the second quarter, management now expects at least 1.25 for the year. Progress on PAC-3 solid rocket motor production awards, the missile multi-year agreements worth up to $10 billion, international wins such as Kuwait IBCS and NATO Triton, and any clarity on B-21 expansion ahead of the year-end decision would show the pipeline converting. Free cash flow guidance of $3.1 billion to $3.5 billion, which held last quarter, is also worth checking after a nearly $1 billion second quarter.

Sentiment has edged from slightly bearish before the last report to slightly bullish now, a modest improvement that hardly signals euphoria. The chart is less forgiving. At about $481, the stock sits well below its 200-day moving average near $596 and only around 2% above its post-earnings low of $470, having already broken beneath the prior quarter's floor of roughly $494.

That combination sets up a clear test. Momentum in backlog and demand appears to be strengthening, but the market wants evidence that earnings quality matches it. If Northrop reaffirms or nudges up its raised outlook without fresh charges at Defense Systems or Space, the gap between guidance and consensus could start to close in management's favor. If the troubled programs bleed again, the stock's weakness will look like it was warning about something real.